Search Site:
Research Programs
Basic Sciences Division
Clinical Sciences Division
Cancer Prevention and Control
Prostate Cancer SPORE
R.A.D.A.R.
Shared Resources
Bioinformatics Core
Biostatistics Core
Cancer Diagnostic and Therapeutics Screening
Cell Imaging Facility
Clinical Pharmacology Core
Clinical Research Office
Flow Cytometry Facility
Genomics Core Facility
Keck Biophysics Facility
Monoclonal Antibody Facility
Mouse Histology & Phenotyping Laboratory
Outcomes Measurement and Survey Core
Pathology Core Facility
Structural Biology Facility
Transgenic and Targeted Mutagenesis Laboratory
Member Directory
Search All Members
Non-Programmatically Aligned Members
Professional Education
Grand Rounds
Lynn Sage Breast Cancer Symposium
Tumor Cell Biology
Poster Session
Training and Travel
CURE Program
Fellowship Programs
Training Programs
Travel Grants
Master of Biotechnology Program
News
Recent News
Cancer Center Journals
Quarterly Newsletters
Annual Reports and Reviews
Notable Cancer Center Members
Corporate Standards
About Us
Cancer Center Leadership
Affiliated Institutions
Contact Us
Clinical Cancer Center
Job Opportunities
How to Help
Maps and Directions
About Robert H. Lurie
Annual Reports & Review
Basic Sciences
|
Clinical Sciences
|
Cancer Prevention & Control
|
Prostate Cancer SPORE
|
R.A.D.A.R.
RADAR
>
Publications
> Articles published by RADAR
RADAR Home
|
RADAR Publications
|
Adverse Events
|
Contact Us
|
About RADAR
|
Links
Articles published
by
RADAR
|
Articles published
about
RADAR
|
White Papers
Articles published by RADAR
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
Home
|
About the Lurie Cancer Center
|
Patients and Visitors
|
How to Contribute
|
Northwestern University
|
Search
